BioAtla BCAB
NASDAQ BCAB
$1.40 +0.08 (+6.06%)
At close: Sep 8, 2026 · 4:00 PM EDT

BioAtla (BCAB) Current Leases (2021 - 2026)

BioAtla's (BCAB) quarterly Current Leases came in at $1.6 million in Q2 2026, up 95.03% on a YoY basis from $805000.0 in Q2 2025, and up 0.71% quarter-over-quarter from $1.6 million in Q1 2026.

Analysis

BioAtla (BCAB) Current Leases (2021 - 2026) Analysis & Trends

BioAtla (BCAB) has reported Current Leases for 6 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Leases rose 95.03% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 million (up 95.03% YoY), and the FY2025 full-year result was $1.4 million, up 70.69% from the prior year.
  • Current Leases improved to $1.6 million in Q2 2026 per BCAB's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.7 million in Q2 2024 and bottomed at $554000.0 in Q1 2025.
  • Historically, Current Leases has averaged $1.4 million across 5 years, with a median of $1.5 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Current Leases plunged 63.29% in 2025, then soared 181.41% in 2026.
  • Over 5 years, Current Leases stood at $1.5 million in 2022, then increased by 6.77% to $1.6 million in 2023, then slumped by 48.52% to $836000.0 in 2024, then jumped by 70.69% to $1.4 million in 2025, then grew by 10.02% to $1.6 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $1.6 million, $1.6 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 11.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 12.38 Mn
10 BioAtla 2.33 Mn 2.33 Mn - 1.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.57 Mn
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.43 Mn
Sep 30, 2025 1.17 Mn
Jun 30, 2025 805,000.00
Mar 31, 2025 554,000.00
Dec 31, 2024 836,000.00
Sep 30, 2024 1.25 Mn
Jun 30, 2024 1.66 Mn
Mar 31, 2024 1.51 Mn
Dec 31, 2023 1.62 Mn
Sep 30, 2023 1.60 Mn
Jun 30, 2023 1.57 Mn
Mar 31, 2023 1.55 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 1.50 Mn
Jun 30, 2022 1.48 Mn
Mar 31, 2022 1.43 Mn
Dec 31, 2021 1.39 Mn